Expert Opinion on Drug Metabolism and Toxicology

Top Research Topics at Expert Opinion on Drug Metabolism & Toxicology?

Expert Opinion on Drug Metabolism & Toxicology focuses on Pharmacology, Pharmacokinetics, Drug, Internal medicine and Pharmacodynamics. Topics in Pharmacology were tackled in line with various other fields like Pharmacogenetics, Toxicity and In vivo. Expert Opinion on Drug Metabolism & Toxicology focused on Pharmacogenetics research but expanded to cover Pharmacogenomics.

In vivo research discussed connects with the study of In vitro. Pharmacokinetics research presented in it encompasses a variety of subjects, including Bioavailability, Tolerability, Distribution (pharmacology) and Dosing. While the primary focus in the journal is Drug, it also dissects topics surrounding Intensive care medicine and MEDLINE as a whole.

The journal tackles studies in Oncology and the interrelated subject of Chemotherapy to gain insights into Internal medicine. The study of Biochemistry serves as the foundation of the Drug metabolism research discussed in Expert Opinion on Drug Metabolism & Toxicology. The work on Biochemistry presented in Expert Opinion on Drug Metabolism & Toxicology focuses on Xenobiotic in particular.

• Pharmacology (47.83%)
• Pharmacokinetics (29.70%)
• Drug (27.36%)

What are the most cited papers published in the journal?

• Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. (944 citations)
• Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. (543 citations)
• The Simcyp® population-based ADME simulator (374 citations)

Research areas of the most cited articles at Expert Opinion on Drug Metabolism & Toxicology:

The published papers mainly tackle studies in Pharmacology, Drug, Pharmacokinetics, Drug metabolism and Biochemistry. The published articles focus on Pharmacology but the discussions also offer insight into other areas such as Transporter, Toxicity and In vivo. The journal articles deal with Drug in conjunction with Bioinformatics and similar fields in Disease.

What topics the last edition of the journal is best known for?

• Internal medicine
• Cancer
• Enzyme

The previous edition focused in particular on these issues:

Expert Opinion on Drug Metabolism & Toxicology mainly deals with areas of study such as Pharmacokinetics, Pharmacology, Drug, Intensive care medicine and Internal medicine. The works on Pharmacokinetics deal in particular with Pharmacodynamics. The featured Pharmacology studies mainly concentrate on Transporter but also cover areas of interest in Kidney.

The journal is focused mainly on Drug, particularly Drug metabolism. While the journal focused on Intensive care medicine, it was also able to explore topics like Pharmacogenetics, Adverse effect, Therapeutic drug monitoring and Increased risk. The journal explores issues in Internal medicine which can be linked to other research areas like Gastroenterology and Oncology.

The most cited articles from the last journal are:

• Tumor grafted – chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation (6 citations)
• Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity. (5 citations)
• Alterations in drug disposition in older adults: a focus on geriatric syndromes. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Expert Opinion on Drug Metabolism & Toxicology (based on the number of publications) are:

• André Scheen (12 papers) absent at the last edition,
• Simone Ferrero (12 papers) absent at the last edition,
• Maria Gabriella Matera (11 papers) absent at the last edition,
• Mario Cazzola (10 papers) absent at the last edition,
• Mohammad Abdollahi (10 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Opinion on Drug Metabolism & Toxicology (based on the number of publications) are:

• Pfizer (35 papers) published 1 paper at the last edition the same number as at the previous edition,
• University of Bologna (20 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Sapienza University of Rome (20 papers) absent at the last edition,
• The Chinese University of Hong Kong (19 papers) absent at the last edition,
• Boston Children's Hospital (19 papers) published 1 paper at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.17% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 4.35% were posted by at least one author from the top 10 institutions publishing in the journal. Another 1.09% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.57% of all publications and 75.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Researched Schools and Institutions

The Expert Opinion on Drug Metabolism & Toxicology bridges the gap between academia and industry by publishing research from a wide range of institutions. Garnering representation from various universities and research institutions globally, the journal contributes mainly to the medicinal and pharmacological research sector. Significantly, multiple contributors are from renowned and accredited nursing and medical schools that consistently strive to foster progress in these fields. One important contributor from accredited educational institutions is the Best Nursing Schools in New Hampshire. It conducts extensive research on Drug Metabolism and Toxicology, encouraging their students and faculty to bring forward innovations within the industry. They are also dedicated to bridging the knowledge gap by encouraging multidisciplinary research in conjunction with other medicinal disciplines to provide a holistic view of Medicine and Pharmacy. The journal's geographical and institutional diversity helps in providing a holistic view of the research domain, showcasing perspectives from various corners of the world, thus encouraging an atmosphere of learning, growth, and innovation. The following list shares the Top institution contributions to the research published in 2021:

1. John Hopkins University, Baltimore, USA
2. The University of Manchester, United Kingdom
3. The University of Social Welfare, Tokyo, Japan